BASSET, MARCO

BASSET, MARCO  

DIPARTIMENTO DI MEDICINA MOLECOLARE  

Mostra records
Risultati 1 - 20 di 34 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis 1-gen-2020 Caccialanza, R.; Cereda, E.; Klersy, C.; Milani, P.; Cappello, S.; Martinelli, V.; Turri, A.; Basset, M.; Borioli, V.; Nuvolone, M.; Caraccia, M.; Lavatelli, F.; Masi, S.; Lobascio, F.; Foli, A.; Merlini, G.; Palladini, G.
A biomarker-based approach in management of AL amyloidosis: from risk assessment to tailored-treatment strategy 6-apr-2022 Basset, Marco
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 1-gen-2017 Palladini, Giovanni; Jaccard, Arnaud; Milani, Paolo; Lavergne, David; Foli, Andrea; Bender, Sebastien; Lavatelli, Francesca; Bosoni, Tiziana; Valentini, Veronica; Pirolini, LAURA MARIA; Ferraro, Giovanni; Basset, Marco; Russo, Francesca; Nuvolone, MARIO ULISSE; Albertini, Riccardo; Cogne, Michel; Merlini, Giampaolo
Daratumumab in light chain deposition disease: Rapid and profound hematologic response preserves kidney function 1-gen-2020 Milani, P.; Basset, M.; Curci, P.; Foli, A.; Rizzi, R.; Nuvolone, M.; Guido, R.; Gesualdo, L.; Specchia, G.; Merlini, G.; Palladini, G.
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 1-gen-2015 Palladini, Giovanni; Sachchithanantham, S.; Milani, Paolo; Gillmore, J.; Foli, Andrea; Lachmann, H.; Basset, Marco; Hawkins, P.; Merlini, Giampaolo; Wechalekar, A. D.
Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis 1-gen-2018 Kastritis, Efstathios; Papassotiriou, Ioannis; Merlini, Giampaolo; Milani, Paolo; Terpos, Evangelos; Basset, Marco; Akalestos, Athanasios; Russo, Francesca; Psimenou, Erasmia; Apostolakou, Filia; Roussou, Maria; Gavriatopoulou, Maria; Eleutherakis Papaiakovou, Evangelos; Fotiou, Despina; Ziogas, Dimitrios C; Papadopoulou, Elektra; Pamboucas, Constantinos; Dimopoulos, Meletios A; Palladini, Giovanni
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis 1-gen-2018 Kastritis, E.; Papassotiriou, I.; Merlini, G.; Milani, P.; Terpos, E.; Basset, M.; Akalestos, A.; Russo, F.; Psimenou, E.; Apostolakou, F.; Roussou, M.; Gavriatopoulou, M.; Eleutherakis-Papaiakovou, E.; Fotiou, D.; Ziogas, D. C.; Papadopoulou, E.; Pamboucas, C.; Dimopoulos, M. A.; Palladini, G.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate 1-gen-2020 Milani, P.; Fazio, F.; Basset, M.; Berno, T.; Larocca, A.; Foli, A.; Riva, M.; Benigna, F.; Oliva, S.; Nuvolone, M.; Rodigari, L.; Petrucci, M. T.; Merlini, G.; Palladini, G.
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 1-gen-2017 Russo, Francesca; Valentini, Veronica; Basset, Marco; Bosoni, Tiziana; Milani, Paolo; Ferraro, Giovanni; Pirolini, LAURA MARIA; Foli, Andrea; Lavatelli, Francesca; Belvisi, Fabrizio; Consogno, Giorgio; Nuvolone, MARIO ULISSE; Li Bergolis, Filomena; Bozzola, Margherita; Albertini, Riccardo; Palladini, Giovanni; Merlini, Giampaolo
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis 1-gen-2016 Palladini, Giovanni; Milani, Paolo; Foli, Andrea; Basset, Marco; Russo, Francesca; Bosoni, T.; Pirolini, LAURA MARIA; Valentini, Veronica; Ferraro, Giovanni; Lavatelli, Francesca; Barassi, Alessandra; Albertini, Riccardo; Merlini, Giampaolo
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy 1-gen-2020 Milani, P.; Basset, M.; Nuvolone, M.; Benigna, F.; Rodigari, L.; Lavatelli, F.; Foli, A.; Merlini, G.; Palladini, G.
The lung in amyloidosis 1-gen-2017 Milani, P.; Basset, M.; Russo, F.; Foli, A.; Palladini, G.; Merlini, G.
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis 1-gen-2021 Palladini, G.; Paiva, B.; Wechalekar, A.; Massa, M.; Milani, P.; Lasa, M.; Ravichandran, S.; Krsnik, I.; Basset, M.; Burgos, L.; Nuvolone, M.; Lecumberri, R.; Foli, A.; Puig, N.; Sesta, M. A.; Bozzola, M.; Cascino, P.; Nevone, A.; Ripepi, J.; Berti, P.; Casarini, S.; Annibali, O.; Orfao, A.; San-Miguel, J.; Merlini, G.
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis 1-gen-2020 Basset, M.; Defrancesco, I.; Milani, P.; Nuvolone, M.; Rattotti, S.; Foli, A.; Mangiacavalli, S.; Varettoni, M.; Benvenuti, P.; Cartia, C. S.; Paulli, M.; Merlini, G.; Arcaini, L.; Palladini, G.
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside 1-gen-2020 Basset, M.; Nuvolone, M.; Palladini, G.; Merlini, G.
A patient with AL amyloidosis with negative free light chain results 1-gen-2016 Milani, Paolo; Valentini, Veronica; Ferraro, Giovanni; Basset, Marco; Russo, Francesca; Foli, Andrea; Palladini, Giovanni; Merlini, Giampaolo
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome 1-gen-2017 Milani, Paolo; Basset, Marco; Russo, Francesca; Foli, Andrea; Lavatelli, Francesca; Nuvolone, MARIO ULISSE; Ferraro, Giovanni; Palladini, Giovanni; Merlini, Giampaolo
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome 1-gen-2017 Milani, Paolo; Basset, Marco; Russo, Francesca; Foli, Andrea; Merlini, Giampaolo; Palladini, Giovanni
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 1-gen-2017 Basset, Marco; Milani, Paolo; Russo, Francesca; Lavatelli, Francesca; Nuvolone, MARIO ULISSE; Foli, Andrea; Perlini, Stefano; Palladini, Giovanni; Merlini, Giampaolo
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 1-gen-2017 Palladini, G.; Milani, P.; Foli, A.; Basset, M.; Russo, F.; Perlini, S.; Merlini, G.